PIK3CA mutation rewires immune and metabolic networks in cervical cancer cells
CRISPR-engineered cervical cancer cells carrying the PIK3CA-E545K mutation show coordinated immune signaling and metabolic rewiring, driven by suppressed lipid biosynthesis ...










